X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with JUBILANT LIFE SCIENCES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs JUBILANT LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB JUBILANT LIFE SCIENCES UNICHEM LAB/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x -64.1 17.1 - View Chart
P/BV x 0.7 4.5 16.0% View Chart
Dividend Yield % 2.4 0.4 581.5%  

Financials

 UNICHEM LAB   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
JUBILANT LIFE SCIENCES
Mar-14
UNICHEM LAB/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs382187 204.5%   
Low Rs23465 359.6%   
Sales per share (Unadj.) Rs116.3364.3 31.9%  
Earnings per share (Unadj.) Rs-18.96.8 -276.4%  
Cash flow per share (Unadj.) Rs-11.724.5 -47.9%  
Dividends per share (Unadj.) Rs5.003.00 166.7%  
Dividend yield (eoy) %1.62.4 68.1%  
Book value per share (Unadj.) Rs381.0164.9 231.1%  
Shares outstanding (eoy) m70.34159.28 44.2%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.60.3 766.3%   
Avg P/E ratio x-16.318.4 -88.5%  
P/CF ratio (eoy) x-26.25.1 -510.4%  
Price / Book Value ratio x0.80.8 105.9%  
Dividend payout %-26.443.8 -60.3%   
Avg Mkt Cap Rs m21,66820,061 108.0%   
No. of employees `0002.36.2 36.9%   
Total wages/salary Rs m2,00611,052 18.2%   
Avg. sales/employee Rs Th3,587.89,383.0 38.2%   
Avg. wages/employee Rs Th880.01,786.9 49.2%   
Avg. net profit/employee Rs Th-583.7176.3 -331.1%   
INCOME DATA
Net Sales Rs m8,18058,034 14.1%  
Other income Rs m610191 320.1%   
Total revenues Rs m8,79058,224 15.1%   
Gross profit Rs m-1,3205,786 -22.8%  
Depreciation Rs m5052,812 18.0%   
Interest Rs m803,237 2.5%   
Profit before tax Rs m-1,295-72 1,796.5%   
Minority Interest Rs m0-286 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m02,145 0.0%   
Tax Rs m33696 4.8%   
Profit after tax Rs m-1,3311,090 -122.1%  
Gross profit margin %-16.110.0 -161.9%  
Effective tax rate %-2.6-965.9 0.3%   
Net profit margin %-16.31.9 -865.9%  
BALANCE SHEET DATA
Current assets Rs m23,31829,280 79.6%   
Current liabilities Rs m4,63538,912 11.9%   
Net working cap to sales %228.4-16.6 -1,376.2%  
Current ratio x5.00.8 668.5%  
Inventory Days Days12284 144.3%  
Debtors Days Days12151 239.6%  
Net fixed assets Rs m8,16355,712 14.7%   
Share capital Rs m141155 91.1%   
"Free" reserves Rs m26,66020,968 127.1%   
Net worth Rs m26,80126,265 102.0%   
Long term debt Rs m317,169 0.0%   
Total assets Rs m31,89088,606 36.0%  
Interest coverage x-15.21.0 -1,551.7%   
Debt to equity ratio x00.7 0.0%  
Sales to assets ratio x0.30.7 39.2%   
Return on assets %-3.94.9 -80.3%  
Return on equity %-5.04.2 -119.6%  
Return on capital %-4.511.6 -39.3%  
Exports to sales %037.8 0.0%   
Imports to sales %016.5 0.0%   
Exports (fob) Rs mNA21,933 0.0%   
Imports (cif) Rs mNA9,567 0.0%   
Fx inflow Rs m4,35622,004 19.8%   
Fx outflow Rs m011,749 0.0%   
Net fx Rs m4,35610,255 42.5%   
CASH FLOW
From Operations Rs m-1,1238,026 -14.0%  
From Investments Rs m16,487-1,744 -945.2%  
From Financial Activity Rs m-8,811-4,447 198.1%  
Net Cashflow Rs m6,5521,834 357.2%  

Share Holding

Indian Promoters % 50.1 45.6 109.9%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 15.1 8.7 173.6%  
FIIs % 3.0 21.2 14.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 21.1 150.2%  
Shareholders   20,176 23,815 84.7%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   STERLING BIOTECH  PFIZER  ALEMBIC PHARMA  ELDER PHARMA  ALEMBIC LTD  

Compare UNICHEM LAB With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY19); Net Profit Up 39.4% (Quarterly Result Update)

Jul 31, 2018 | Updated on Jul 31, 2018

For the quarter ended June 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 39.4% YoY). Sales on the other hand came in at Rs 21 bn (up 30.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Sep 21, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS